Cardiowell and ONEai Health Announce Strategic Partnership
Cardiowell, a leading virtual healthcare company specializing in hypertension management, and ONEai Health, an innovator in continuous biometric surveillance and disease-specific AI, today announced a strategic partnership to redefine the future of chronic disease management and acute incident prevention. The two companies aim to leverage their combined expertise to deliver cutting-edge, sensor-based predictive analytics solutions that empower clinicians and patients alike.
This collaboration marks a significant step in applying advanced artificial intelligence to proactive healthcare. Combining Cardiowell’s patient-centered approach to hypertension management with ONEai Health’s real-time biometric monitoring and predictive analytics, the partnership seeks to reduce emergency department visits and hospital admissions while preventing life-threatening acute incidents such as strokes.
“This partnership represents a convergence of technology and care,” said Yair Lurie, CEO of Cardiowell. “By combining our expertise in hypertension management with ONEai Health’s innovative AI capabilities, we’re taking a monumental step towards personalized, preventative care. Together, we’ll empower patients to take control of their health while giving clinicians the tools to act proactively, potentially preventing chronic complications and acute events like strokes.”
Transforming Chronic Disease and Acute Event Management
The partnership will focus on developing an integrated platform that combines:
• Real-Time Biometric Monitoring: Advanced sensors and wearables to capture critical patient data continuously.
• Predictive Analytics: AI-powered algorithms forecasting potential acute events, including strokes and hypertensive crises, allowing for timely interventions.
• Actionable Insights: Personalized, data-driven recommendations to help patients manage their blood pressure and adhere to treatment plans.
“The future of healthcare lies in predictive and preventive care,” said Rob Fisher, CEO of ONEai Health. “Our collaboration with Cardiowell allows us to extend our AI-driven solutions into hypertension management and acute event prevention, critical areas with far-reaching impacts on global health. This partnership is about delivering real-time insights that translate into real-world outcomes.”
Key Benefits to Patients and Clinicians
The joint solution aims to:
• Improve patient engagement and adherence to care plans.
• Reduce the frequency and severity of acute hypertensive episodes and incidents such as strokes.
• Enhance clinician decision-making with predictive tools.
• Lower healthcare costs by preventing unnecessary hospitalizations and emergency department visits.
• Provide a direct-to-consumer solution that allows individuals to self-care while connecting with a panel of available health coaches and medical specialists for support.
A Vision for the Future
Cardiowell and ONEai Health are committed to creating a more proactive and connected healthcare ecosystem. By combining their resources and expertise, they aim to set a new standard for chronic disease management and acute event prevention. They offer scalable solutions for hypertension and beyond.
About Cardiowell
Cardiowell is a virtual healthcare company that empowers individuals to manage hypertension through innovative technology and patient-centric solutions. Cardiowell is transforming how hypertension is treated by integrating predictive analytics and personalized care.
About ONEai Health
ONEai Health specializes in continuously surveilling patients’ biometrics and disease-specific AI-powered analytics. Their solutions enable clinicians to intervene proactively, improving patient outcomes and reducing healthcare system burdens.
